FidoCure® pricing

TL;DR: FidoCure® does not publish a price list we can verify, which is normal for Healthcare companies at this stage. Below: what we can confirm, how to get a real quote, and 8 comparable tools to benchmark the number against.

What is verifiable about FidoCure® pricing, how to get a real quote, and 8 comparable tools to price it against.

Company
FidoCure®
Category
Healthcare
YC batch
Winter 2018
Status
Active
Team size
14
Public price list
Not published

Last verified:

Does FidoCure® publish its pricing?

Not in any source we can verify. FidoCure® is a Y Combinator-backed Healthcare company from the Winter 2018 batch, and companies at this stage usually quote per customer rather than publish rate cards. We will not guess at a number — anything quoted elsewhere without a source is guesswork too. The company profile we work from is the Y Combinator listing; the current figure has to come from FidoCure® directly.

How to get an accurate FidoCure® quote

  1. Ask for pricing at your actual volume, not the headline tier — per-seat and usage pricing diverge fast.
  2. Ask what happens at renewal. Uplift caps matter more than the first-year discount.
  3. Get the onboarding, migration and support costs in writing separately.
  4. Ask for a month-to-month option. If it does not exist, that tells you about the annual price.
  5. Quote a competitor from the table below. It is the fastest way to a real number.

FidoCure® pricing compared to competitors

These are the closest comparable tools, matched on what FidoCure® actually does. Price each one alongside it — stage and team size are a reasonable proxy for where a vendor sits on price.

Compare againstWhat it doesStageTeam
Mind Emulation FoundationYC Winter 20181
BiocognivYC Summer 20206
DocbotYC Winter 2019
ExcepgenYC Winter 20193
FurmacyDigital e-prescribing software for veterinarians.YC Winter 20215
Kenota (formerly ExVivo Labs)Kenota is revolutionizing the way we test for diseaseYC Summer 201635
MoichorAI Powered Animal DiagnosticsYC Winter 202129
ResistanceBioWe solve drug resistance for cancerYC Winter 201915

Is FidoCure® worth the cost?

That depends on a number we cannot see, so judge it on what we can: FidoCure® is currently Active with a team of around 14. A small team means faster support and more negotiating room, but more risk of the product changing direction. A larger or public vendor costs more and moves slower. If price is the deciding factor, the earlier-batch companies in the table are usually the ones still competing on it.

See all FidoCure® alternatives compared →

Built by LemStudio

Building or buying SaaS? Try our founder tools →

Explore related

Loading interactive view…